Radiotherapy enhancement with gold nanoparticles

Authors: Hainfeld, James F.1; Dilmanian, F. Avraham2; Slatkin, Daniel N.2; Smilowitz, Henry M.2

Source: Journal of Pharmacy and Pharmacology, Volume 60, Number 8, August 2008 , pp. 977-985(9)

Publisher: Pharmaceutical Press

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Gold is an excellent absorber of X-rays. If tumours could be loaded with gold, this would lead to a higher dose to the cancerous tissue compared with the dose received by normal tissue during a radiotherapy treatment. Calculations indicate that this dose enhancement can be significant, even 200% or greater. In this paper, the physical and biological parameters affecting this enhancement are discussed. Gold nanoparticles have shown therapeutic efficacy in animal trials and these results are reviewed. Some 86% long-term (>1 year) cures of EMT-6 mouse mammary subcutaneous tumours was achieved with an intravenous injection of gold nanoparticles before irradiation with 250-kVp photons, whereas only 20% were cured with radiation alone. The clinical potential of this approach is also discussed.

Document Type: Research article

DOI: 10.1211/jpp.60.8.0005

Affiliations: 1: Nanoprobes, Inc., 95 Horseblock Road, Yaphank, NY 11980-9710, USA., Email: hainfeld@nanoprobes.com 2: Nanoprobes, Inc., 95 Horseblock Road, Yaphank, NY 11980-9710, USA

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$38.49 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A